PlumX Metrics
Embed PlumX Metrics

Reinvestigation of Mycothiazole Reveals the Penta-2,4-dien-1-ol Residue Imparts Picomolar Potency and 8

ACS Med Chem Lett, Vol: 11, Issue: 2, Page: 108-113
2020
  • 0
    Citations
  • 12
    Usage
  • 0
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Reinvestigation of mycothiazole (1) revealed picomolar potency (IC50 = 0.00016, 0.00027, 0.00035 muM) against pancreatic, (PANC-1), liver (HepG2), and colon (HCT-116) tumor cell lines. Reevaluation of 1 provided [alpha]D data indicating Vanuatu specimens of C. mycofijiensis contain the 8S enantiomer of 1 and not the 8R configuration previously reported. Semisynthesis provided 8-O-acetylmycothiazole (2), 8-oxomycothiazole (8), mycothiazole nitrosobenzene derivatives (MND1, MND2: 9a, 9b), and MND3 (10) with IC50 = 0.00129, >1.0, >1.0, >1.0, >1.0 muM, respectively, against PANC-1 cell lines. These results highlight the significance of the penta-2,4-dien-1-ol residue as a key structural feature of 1 required for its cytotoxicty against tumor cell lines.

Bibliographic Details

Tyler A Johnson; Joseph D Morris; David A Coppage; Colon V Cook; Lauren N Persi; Marcos A Ogarrio; Taylor C Garcia; Nicole L McIntosh; Erin P McCauley; Joe Media; Mani Maheshwari; Frederick A Valeriote; Jiajiu Shaw; Phillip Crews

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know